Albireo Pharma Inc. buy Mori8
Start price
15.12.16
/
50%
€20.99
Target price
08.03.17
€26.05
Performance (%)
4.86%
End price
08.03.17
€22.01
Summary
This prediction ended on 08.03.17 with a price of €22.01. With a performance of 4.86%, the BUY prediction by Mori8 for Albireo Pharma Inc. closed with a slight gain. Mori8 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Albireo Pharma Inc. | - | - | - | - |
| iShares Core DAX® | 0,41 % | 8,82 % | 12,26 % | 49,53 % |
| iShares Nasdaq 100 | 3,68 % | 10,82 % | 44,02 % | 96,25 % |
| iShares Nikkei 225® | 2,70 % | 15,25 % | 48,04 % | 64,69 % |
| iShares S&P 500 | 2,44 % | 7,93 % | 33,00 % | 67,57 % |
Comments by Mori8 for this prediction
In the thread Albireo Pharma Inc. diskutieren
Mori8 stimmt der Buy-Einschätzung von Quitte zu
Mori8 stimmt am 15.12.2016 der Buy-Einschätzung von Quitte mit dem Kursziel 21€ zu.Überschrift: schuldenfrei und Merger in Sicht
(Vom Mitglied beendet)
Stopped prediction by Mori8 for Albireo Pharma Inc.
Albireo Pharma Inc.
Start price
Target price
Perf. (%)
€21.25
14.03.17
14.03.17
€28.28
13.07.17
13.07.17
5.88%
13.07.17
13.07.17
Albireo Pharma Inc.
Start price
Target price
Perf. (%)
€11.04
20.09.16
20.09.16
€17.64
14.12.16
14.12.16
111.06%
14.12.16
14.12.16


